• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES SAPIEN 3 PULMONIC DELIVERY SYSTEM; PULMONARY VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES SAPIEN 3 PULMONIC DELIVERY SYSTEM; PULMONARY VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number 9630PL29A
Medical Device Problem Code Difficult to Remove (1528)
Health Effect - Clinical Code Unspecified Vascular Problem (4441)
Date of Event 07/08/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Investigation is still ongoing.
 
Event or Problem Description
As reported by the field clinical specialist (fcs), during an alterra transfemoral tmvr procedure with a 29 mm sapien 3 valve, a vascular complication occurred upon removal of the pulmonic delivery system (pds).The pds was removed from the pa and into the ivc; however, the system was pulled so quickly that the team was not able to catch the fluro imaging to 'marry' the capsule to the tapered tip prior to device removal.This led to the tapered tip getting "caught" in the vessel and was unable to be removed.The capsule and part of the balloon was out of the patient's body, but the tapered tip remained stuck in the vasculature.The implanting physician enlarged the venotomy however the device still could not be removed.Vascular surgery was called to performed a cutdown for device removal from the femoral vein.The tapered tip and balloon were intact, and the patient remained hemodynamically stable throughout procedure.
 
Additional Manufacturer Narrative
Correction to h6 based on additional information.Note: this mdr was originally submitted within the 30-day timeline, but due to a technical issue experienced during the submission process, acknowledgment 3 was not received.The mdr was confirmed to be transmitted properly, as we received acknowledgement 1 and 2, but this issue could not be resolved through the esg help desk, so this mdr has been resubmitted.Please reference esg and cesub support reference numbers: (b)(6).The device was not returned to edwards lifesciences for evaluation, however, a device history record (dhr) review was done, and did not reveal any manufacturing nonconformance issues that would have contributed to the event.A lot history review was performed and revealed no other complaints relating to the reported event were identified.The instructions for use/training manuals were reviewed for guidance/instruction involving the esheath and delivery system usage.Based on the review of the ifu/training manuals, no deficiencies were identified.A review of edwards lifesciences risk management documentation was performed for this case.The reported event is an anticipated risk of the transcatheter heart valve procedure, additional assessment of the failure mode is not required at this time.The complaints for withdrawal difficulty from vasculature was unable to be confirmed.Due to unavailability of the device, engineering was unable to be perform any visual, functional, or dimensional analysis.Therefore, a manufacturing non-conformance was unable to be determined.As reported, 'the pds was removed from the pa and into the ivc; however, the system was pulled so quickly that the team was not able to catch the fluro imaging to 'marry' the capsule to the tapered tip prior to device removal.Therefore, the capsule and part of balloon was out of patient body, but the tapered tip got 'caught' and remained stuck in vasculature.' as such, it possible the hasty withdrawal of the delivery system without the retraction of the capsule led to the difficulties with withdrawal.Due to limited information, a definitive root cause was unable to be determined.However, available information suggests that procedural factors (improper withdrawal technique) contributed to the withdrawal difficulty.Complaint histories for all reported events are reviewed against trending control limits monthly, and any excursions above the control limits are assessed and documented as part of this monthly review.No corrective or preventative actions are required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SAPIEN 3 PULMONIC DELIVERY SYSTEM
Common Device Name
PULMONARY VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer (Section G)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
Manufacturer Contact
renee van dorne
1 edwards way
irvine, CA 92614
9492506385
MDR Report Key15161576
Report Number2015691-2022-07159
Device Sequence Number5748279
Product Code NPV
UDI-Device Identifier00690103210873
UDI-Public(01)00690103210873(17)230714(11)2107142163856029
Combination Product (Y/N)N
Initial Reporter StateCA
Initial Reporter CountryUS
PMA/510(K) Number
P200015
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,User Facility,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 11/08/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/14/2023
Device Model Number9630PL29A
Device Catalogue Number9630PL29A
Device Lot Number63856029
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/08/2022
Supplement Date Received by Manufacturer09/22/2022
Initial Report FDA Received Date08/03/2022
Supplement Report FDA Received Date11/08/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured06/21/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexUnknown
-
-